Year : 2019  |  Volume : 13  |  Issue : 1  |  Page : 6-9

Antiplatelet therapy and the anaesthetist

Royal Brompton Hospital, Sydney Street, London, Great Britain

Correspondence Address:
Sian I Jaggar
Royal Brompton Hospital, Sydney Street, London SW3 6NP, Great Britain

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ejca.ejca_18_18

Rights and Permissions

Increasing numbers of patients internationally are taking dual antiplatelet therapy (DAPT). Both continuing and stopping this treatment may be risky for the patient. It is vital to consider the competing thrombotic and bleeding risks in the perioperative period. It is incumbent upon anaesthetists to maintain their knowledge base in this rapidly developing area. This article provides information to support practice as.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded89    
    Comments [Add]    

Recommend this journal